PMDIY (Pro Medicus) Growth Rank: 10 (As of Aug. 09, 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PMDIY Pro Medicus Ltd PMDIY
77 GF Score
Price $29.51
GF Value $40.51
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Pro Medicus Growth Rank?

Pro Medicus PMDIY 77 Growth Rank is 10 as of Aug. 09, 2026, which is at its 10-year median of 10.00. GuruFocus rates PMDIY with a GF Score™ of 77/100 and a GF Value™ of $40.51 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Pro Medicus has the Growth Rank of 10.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

PMDIY vs VEEV, BTSG, HQY: Growth Rank Comparison

For the Health Information Services subindustry, Pro Medicus's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pro Medicus Growth Rank vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pro Medicus's Growth Rank distribution charts can be found below:

* The bar in red indicates where Pro Medicus's Growth Rank falls into.


PMDIY
77GF Score
Pro Medicus Ltd PMDIY
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 10 mean?
Pro Medicus (PMDIY) has a Growth Rank of 10 as of Aug. 09, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Pro Medicus and its competitors. This is near median its historical median of 10.00. Over the past decade, Pro Medicus' Growth Rank has ranged from 10.00 to 10.00.
Is Pro Medicus' Growth Rank too high?
Pro Medicus' current Growth Rank of 10 is near median its 10-year median of 10.00. Over the past 10 years, this metric has ranged from a low of 10.00 to a high of 10.00. Overall, Pro Medicus has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pro Medicus' Growth Rank compare to VEEV and BTSG?
Pro Medicus' Growth Rank of 10 can be compared against companies in the Healthcare Providers & Services industry. Historically, Pro Medicus' own Growth Rank has ranged from 10.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Healthcare Providers & Services company?
A good Growth Rank depends on the Healthcare Providers & Services industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Pro Medicus and its competitors. Pro Medicus's current Growth Rank is 10, which is near median its own 10-year median of 10.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pro Medicus stock overvalued right now?
Based on GuruFocus' analysis, Pro Medicus (PMDIY) is currently considered Modestly Undervalued. The stock's GF Value™ is $40.51, compared to a current price of $29.51 — trading 27.2% below its estimated fair value. The current Growth Rank is 10, which is near median its 10-year median of 10.00. Pro Medicus' overall GF Score™ is 77/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Pro Medicus (PMDIY), the current Growth Rank is 10 as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pro Medicus (PMDIY) Overvalued in 2026?

Based on GuruFocus' analysis, Pro Medicus stock appears to be undervalued. The current stock price of $29.51 is trading 27.2% below its estimated GF Value™ of $40.51. GuruFocus considers Pro Medicus to be Modestly Undervalued.

Key valuation signals for PMDIY:

  • Growth Rank: 10 (near median its 10-year median of 10.00)
  • GF Value™: $40.51 vs. price of $29.51 (27.2% below fair value)
  • GF Score™: 77/100 with 1 warning sign

No single metric tells the full story. See the PMDIY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pro Medicus Business Description

Address 450 Swan Street, Richmond, VIC, AUS, 3121
Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are US private academic hospitals. In fiscal 2025, Pro Medicus earned 90% of revenue in North America, 8% from Australia, and the remaining 2% in Europe.
77GF Score

Get the complete analysis for PMDIY

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$29.51
Price
$40.51
GF Value